Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 341 - 360 of 505 trials
Title Investigatorsort icon Disease(s)
A Phase IB Study of GSK3052230 with Chemotherapy in Patients with Metastatic Squamous Cell Lung Cancer or Advanced Pleural Mesothelioma
[Protocol 13-256]
Paik, Paul
  • Lung Cancer, Non-Small Cell
    • Other
  • Mesothelioma
A Phase I Study of Certolizumab plus Chemotherapy for Patients with Stage IV Lung Adenocarcinoma
[Protocol 13-063]
Paik, Paul
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase III Study of Rituximab/Lenalidomide or Rituximab/Chemotherapy Followed by Rituximab Maintenance Therapy in Patients with Previously Untreated Follicular Lymphoma
Newly Diagnosed
[Protocol 12-081]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of IMGN529 in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma
[Protocol 13-073]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Ibrutinib plus Rituximab in Patients with Previously Untreated Follicular Lymphoma
[Protocol 14-018]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of IMO-8400 in Patients with Persistent or Recurrent Waldenstrom's Macroglobulinemia
[Protocol 14-078]
Palomba, M. Lia
  • Hematology
    • Hematologic Malignancies
A Phase I/II Study of Oral Azacitidine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes after Receiving a Stem Cell Transplant from a Donor
[Protocol 13-160]
Papadopoulos, Esperanza
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of Midostaurin to Prevent Relapse After Allogeneic Stem Cell Transplantation in Patients with FLT3-ITD Mutated Acute Myeloid Leukemia
[Protocol 13-242]
Papadopoulos, Esperanza
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase III Study of CMX001 versus Placebo to Prevent Cytomegalovirus (CMV) Infection in Stem Cell Transplant Recipients Already Exposed to CMV
[Protocol 13-182]
Papanicolaou, Genovefa
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
A Study of Posaconazole Versus Micafungin to Protect Against Invasive Fungal Infections in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
[Protocol 10-038]
Papanicolaou, Genovefa
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040]
Park, Jae
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19
Relapsed/Refractory
[Protocol 09-114]
Park, Jae
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of Consolidation Therapy with Autologous T Cells Genetically Targeted to CD19 in Patients with Chronic Lymphocytic Leukemia After Initial Chemotherapy
[Protocol 11-048]
Park, Jae
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
[Protocol 06-138]
Park, Jae
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase II Study of Vemurafenib in Patients with Relapsed or Refractory Hairy Cell Leukemia
Relapsed/Refractory
[Protocol 12-200]
Park, Jae
  • Leukemia
A Phase III Study of Inotuzumab Ozogamicin versus Standard Therapy in Patients with Persistent or Recurrent CD22-Positive Acute Lymphoblastic Leukemia
Relapsed/Refractory
[Protocol 12-262]
Park, Jae
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I/II Study of Low-Dose Cytarabine and Lintuzumab-Ac-225 in Older Patients with Previously Untreated Acute Myeloid Leukemia
Newly Diagnosed
[Protocol 09-053]
Park, Jae
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I/II Study of Intrathecal Trastuzumab in Women with HER2-Positive Breast Cancer that Spread to the Spinal Fluid
[Protocol 12-123]
Pentsova, Elena
  • Breast Cancer
A Phase I/II Study Assessing BPX-501 T Cells Given After Partially Mismatched Related T Cell-Depleted Stem Cell Transplantation in Patients with Hematologic Cancers
[Protocol 13-181]
Perales, Miguel-Angel
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Brentuximab Vedotin for Acute Graft-vs-Host Disease that Persists Despite Steroids
[Protocol 13-232]
Perales, Miguel-Angel
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant